N
ELGX

Natixis’s Endologix Inc ELGX Stock Holding History

Natixis’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,024
Closed -$46K – 1331
2017
Q3 		$46K Buy
+1,024
New +$46.7K ﹤0.01% 1218

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Natixis's ELGX Position: Q4 2017 in Review

Natixis sold out of Endologix Inc (ELGX) in Q4 2017, closing a stake of 1,024 shares — an estimated $46K sold.

Natixis first reported a position in ELGX in Q3 2017 and held it in 1 quarter. The position peaked at $46K in Q3 2017. 103 funds tracked by Wall St. Rank hold ELGX as of Q4 2017.

  • Natixis reported no remaining Endologix Inc position as of Q4 2017 after selling out during the quarter.
  • Natixis sold 1,024 Endologix Inc shares in Q4 2017, an estimated $46K.
  • Natixis first reported a position in Endologix Inc in Q3 2017 and held it in 1 quarter.
  • Natixis's Endologix Inc position peaked at $46K in Q3 2017.
  • 103 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2017.

Based on Natixis's 13F filing for Q4 2017, filed 14 Feb 2018.